Autopsy-Based Lethal-Injection Challenges Are Untimely When Publicly Discoverable and Speculative Without Expert Support

1. Introduction

This warrant-stage decision arises from Dennis Sochor’s sixth successive motion for postconviction relief after the Governor signed a death warrant setting his execution for July 14, 2026. Sochor was convicted of kidnapping and first-degree murder for the 1981 killing of Patricia Gifford and sentenced to death following a 10–2 jury recommendation.

The appeal narrowed to one issue: whether Sochor’s facial challenge to Florida’s three-drug lethal injection protocol—centered on etomidate and alleged “flash pulmonary edema”—was timely and legally sufficient under Florida’s postconviction rules and Eighth/Fourteenth Amendment doctrine. The circuit court summarily denied relief, and Sochor sought a stay of execution.

2. Summary of the Opinion

The Florida Supreme Court affirmed the summary denial and denied a stay. The Court held that Sochor’s method-of-execution claim was:

• Untimely under Florida Rule of Criminal Procedure 3.851 because the “newly discovered evidence” (autopsies of executed inmates from 2017–2026) was discoverable years earlier; and
• Meritless because Florida courts have repeatedly upheld the etomidate-based three-drug protocol and Sochor’s allegations were speculative, particularly without supporting expert evidence.

The Court also declined to hold oral argument, declined to entertain rehearing, and ordered the mandate to issue immediately.

3. Analysis

3.1 Precedents Cited

The opinion is best understood as an application—and tightening—of two recurring lines of Florida postconviction jurisprudence: (1) strict enforcement of timeliness and procedural bars in successive capital litigation; and (2) repeated merits rejections of etomidate-protocol challenges absent competent, non-speculative proof.

A. Standards of review and treatment of successive claims

• Rogers v. State, 409 So. 3d 1257 (Fla.), cert. denied, 145 S. Ct. 2695 (2025): cited for de novo review of summary denials and, later, as authority rejecting an etomidate challenge on the merits. The Court uses Rogers to frame both the appellate posture and the substantive baseline that similar protocol attacks have failed.
• Randolph v. State, 422 So. 3d 166 (Fla.) (quoting Bates v. State, 416 So. 3d 312 (Fla. 2025)), cert. denied, 146 S. Ct. 819 (2025): supplies the operative principle that successive claims may be affirmed as denied if “procedurally barred, untimely, legally insufficient, or refuted by the record.” This is the central doctrinal gateway the Court uses to dispose of Sochor’s claim without an evidentiary hearing.

B. Timeliness and “newly discovered evidence” in capital postconviction

• Bates v. State, 416 So. 3d 312 (Fla. 2025) (citing Wainwright v. State, 411 So. 3d 392 (Fla. 2025)): establishes that even “newly discovered” claims must be filed within one year of when the evidence could have been discovered, not when it was actually obtained.
• Lukehart v. State, 51 Fla. L. Weekly S139 (Fla. May 27), cert. denied, No. 25-7491, 2026 WL 1530138 (U.S. June 1, 2026) (quoting Randolph v. State): used to fix the factual/legal premise that Florida’s “current three-drug protocol has remained essentially unchanged since 2017,” undermining Sochor’s attempt to treat 2017–2026 autopsies as newly emergent grounds.
• Long v. Sec'y, Dep't of Corr., 924 F.3d 1171 (11th Cir. 2019): cited for the historical fact that Florida adopted etomidate in January 2017—reinforcing the Court’s conclusion that the relevant information was discoverable for years.
• Hitchcock v. State, 431 So. 3d 514 (Fla.), cert. denied, No. 25-7255, 2026 WL 1170862 (U.S. Apr. 30, 2026): provides an important records-access rule: postconviction discovery mechanisms “supplement”—not “supplant”—Florida’s public records law (chapter 119). The Court uses Hitchcock to reject Sochor’s argument that warrant-stage practical difficulties in obtaining records make the autopsies “undiscoverable.”

C. Merits standards for lethal-injection challenges and the problem of speculation

• Heath v. State, 426 So. 3d 1253 (Fla.), cert. denied, No. 25-6746, 2026 WL 363902 (U.S. Feb. 10, 2026) (citing Cole v. State, 392 So. 3d 1054 (Fla. 2024)): supplies the evidentiary sufficiency threshold—“speculative and conclusory allegations” about a “substantial risk of serious harm” do not warrant a hearing. The opinion explicitly notes that Sochor inferred pulmonary edema “solely from the autopsy reports and related documents” and lacked an expert affidavit, fitting squarely within Heath/Cole.
• Tanzi v. State, 407 So. 3d 385 (Fla.), cert. denied, 145 S. Ct. 1914 (2025) (citing Asay v. State, 224 So. 3d 695 (Fla. 2017), and Cole v. State): used to state the Court’s repeated approval of the protocol, including etomidate. This line of cases functions as a strong stare decisis anchor: absent materially new, competent evidence or a legal shift, Florida’s Supreme Court will not revisit settled protocol holdings.
• Long v. State, 271 So. 3d 938 (Fla. 2019): cited for rejection of both as-applied and facial challenges, reinforcing that Sochor’s “facial” theory is not novel in kind and has been previously litigated.

D. Treatment of out-of-state and federal developments

• Lee v. Commissioner, Alabama Department of Corrections, No. 26-11864, 2026 WL 1651147 (11th Cir. June 8, 2026): expressly deemed “inapposite” because it involved Alabama’s nitrogen hypoxia, a materially different method. The Court signals it will not treat federal litigation about a different execution method as a lever to reopen Florida’s settled lethal-injection doctrine.

3.2 Legal Reasoning

The Court’s reasoning proceeds in two decisive steps—timeliness first, merits second—each independently sufficient to affirm.

A. Timeliness: “Newly discovered” means discoverable with diligence

Under Rule 3.851(d)(1), Sochor’s claim was decades late unless it fit the “newly discovered evidence” exception in Rule 3.851(d)(2)(A). The Court accepted, for argument’s sake, Sochor’s framing that autopsies from 2017–2026 supported his pulmonary-edema theory, but held the exception still failed because those autopsies were discoverable as they were created, beginning in 2017.

Two features of the opinion are noteworthy:

• Protocol stability matters. Because the three-drug etomidate protocol has been “essentially unchanged since 2017” (Lukehart v. State), the Court treated 2017 as the key date by which diligence was required.
• Public records access defeats “couldn’t get it” narratives. Relying on Hitchcock v. State, the Court emphasized chapter 119 as an available pathway and found unpersuasive Sochor’s argument about other inmates’ limited success in warrant litigation. The Court underscored that Sochor actually obtained the materials via a third party’s public-records request, reinforcing discoverability.

B. Merits: settled protocol approvals and insufficiently supported factual theory

Even if timely, the claim failed on the merits because Florida’s Supreme Court has “repeatedly upheld Florida’s lethal injection protocol, including the etomidate protocol” (Tanzi v. State). The Court also highlighted a pleading/proof defect: Sochor’s pulmonary-edema inference was drawn “solely from the autopsy reports and related documents” and was “speculative,” particularly without an expert affidavit—insufficient under Heath v. State (citing Cole v. State).

The Court therefore affirmed a summary denial—signaling that, in Florida, a warrant-stage facial challenge based on generalized physiological assertions must clear both (1) the diligence-based timeliness hurdle and (2) a non-speculative, expert-supported showing that distinguishes the claim from repeatedly rejected protocol attacks.

3.3 Impact

The opinion’s practical and doctrinal impact is likely to be significant in three ways:

• Higher diligence expectations for “newly discovered” execution-evidence claims. By treating autopsy reports as discoverable when generated (and obtainable under chapter 119), the Court narrows the window for future method-of-execution challenges that rely on post-2017 execution aftermath evidence.
• Reinforced requirement of expert support. The Court’s emphasis on speculation and lack of an expert affidavit indicates that assembling public documents alone is unlikely to trigger hearings; future litigants must translate records into admissible, medically grounded opinions tied to protocol mechanics.
• Limiting effect on last-minute litigation. Combined with immediate mandate, no oral argument, and no rehearing, the decision signals strong institutional preference for finality at the warrant stage where claims could have been brought earlier.

4. Complex Concepts Simplified

• Facial vs. as-applied challenge: A facial challenge argues a policy is unconstitutional in all (or nearly all) applications; an as-applied challenge argues it is unconstitutional in the particular inmate’s circumstances. Sochor brought a facial challenge to Florida’s protocol.
• “Newly discovered evidence” (Rule 3.851): Not evidence that is merely “new to the defense,” but evidence that could not have been found earlier with reasonable diligence. Even then, it must be raised within one year of when it could have been discovered.
• Chapter 119 (public records): Florida’s broad public-records law. The Court emphasized it remains available to postconviction litigants and can make information “discoverable” even if litigation-time discovery is constrained.
• Etomidate protocol: Florida uses etomidate as the first drug intended to render the inmate unconscious, followed by drugs that cause paralysis and death. Sochor alleged etomidate’s effect is too brief and that pulmonary edema causes severe pain.
• “Speculative and conclusory” allegations: Claims stated without concrete, competent support—often requiring expert testimony when medical causation is central. The Court treated Sochor’s interpretation of autopsies as insufficient without expert analysis.
• Brady / Giglio (mentioned but not appealed): Brady v. Maryland concerns nondisclosure of material favorable evidence; Giglio v. United States concerns nondisclosure of evidence affecting witness credibility. The Court’s decision here did not turn on these doctrines because Sochor appealed only the execution-method claim.

5. Conclusion

Dennis Sochor v. State of Florida reinforces a clear rule for Florida capital postconviction practice: a method-of-execution claim framed as “newly discovered” cannot evade Rule 3.851’s time bar when its supporting materials (including execution autopsies) were publicly discoverable years earlier, particularly in a regime where the relevant protocol has remained essentially unchanged. On the merits, the decision reaffirms Florida’s prior approvals of the etomidate protocol and underscores that speculative interpretations of documents—unaccompanied by expert support—will not justify an evidentiary hearing. The result is a strengthened barrier against late-stage, document-only lethal-injection challenges and a renewed emphasis on diligence, competent proof, and finality at the warrant stage.